RSS

clinical data

Biotechnology company, Bavarian Nordic, has revealed positive data from the extension study of its Phase II study investigating its universal respiratory syncytial virus (RSV) vaccine, MVA-BN RSV, in older adults. more

News

A new study from Tufts Center for the Study of Drug Development highlights the need to transform clinical data management practices to enable risk-based approaches and reveals the root causes for delays and inefficiencies impacting trial timelines more

News

Sanofi is requesting that health authorities update information on its dengue vaccine Dengvaxia, as a result of a new analysis of long-term clinical trial data, which found differences in vaccine performance based on prior dengue infection. more

News

Real-world data presented by Merck have demonstrated the long-term clinical effectiveness of golimumab (Simponi) for the treatment of rheumatic diseases. more

News

EPM speaks to clinical technology company Medidata Solutions, to understand how the company is utilising digital health to aid clinical trials. more

News

Laboratory professionals must be given detailed clinical information to make decisions on the most effective testing for patients, writes Martin Wilkinson, Director of Product Introduction, Strategy and User Adoption at InterSystems. more

News

A new software suite for clinical trials has been launched to digitally connect sponsors, sites, medical devices and patients. more

Technology

The Global Alliance for Genomics and Health (GA4GH) has called for clinical and genomic data to be easily accessible on a shared ecosystem more

News

GSK has sponsored the world’s first digitally enhanced randomised controlled trial (RCT) that looks at the effects of Relvar Ellipta on patients with chronic obstructive pulmonary disease (COPD) more

News

Bristol-Myers Squibb has selected Medidata’s Clinical Cloud to help manage, monitor and analyse its clinical trials data more

News

AstraZeneca and Human Longevity (HLI) have announced a ten-year collaboration that enables HLI to sequence and analyse patient samples from AstraZeneca’s clinical trials more

News

Genentech’s phase III studies of ocrelizumab in people with relapsing multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS) show positive results more

News